Primary Site >> Stomach Cancer

Gene >> MAP3K20

Journal: Br J Cancer. 1993 Jun;67(6):1404-7.
Title: Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.
Author: Lissoni, P|Barni, S|Tancini, G|Ardizzoia, A|Rovelli, F|Cazzaniga, M|Brivio, F|Piperno, A|Aldeghi, R|Fossati, D
PMID: 8512825
Journal: Nat Commun. 2014 May 8;5:3830.
Title: Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer.
Author: Liu, Jinfeng|McCleland, Mark|Stawiski, Eric W|Gnad, Florian|Mayba, Oleg|Haverty, Peter M|Durinck, Steffen|Chen, Ying-Jiun|Klijn, Christiaan|Jhunjhunwala, Suchit|Lawrence, Michael|Liu, Hanbin|Wan, Yinan|Chopra, Vivek|Yaylaoglu, Murat B|Yuan, Wenlin|Ha, Con
PMID: 24807215
Journal: Life Sci. 2017 Feb 1;170:41-49.
Title: Transcriptomic analysis of gene expression profiles of stomach carcinoma reveal abnormal expression of mitotic components.
Author: Tong, Hongfei|Wang, Jisheng|Chen, Hui|Wang, Zhaohong|Fan, Henwei|Ni, Zhonglin
PMID: 27923621
Journal: Biochem Biophys Res Commun. 2018 Mar 4;497(2):527-534.
Title: Knockdown of long non-coding RNA MAP3K20 antisense RNA 1 inhibits gastric cancer growth through epigenetically regulating miR-375.
Author: Quan, Yongsheng|Zhang, Yan|Lin, Wei|Shen, Zhaohua|Wu, Shuai|Zhu, Changxin|Wang, Xiaoyan
PMID: 29428732